PTGX

Protagonist Therapeutics, Inc. (PTGX) is a clinical-stage biopharmaceutical company specializing in the development of innovative peptide-based therapies targeting significant unmet medical needs, particularly in gastrointestinal disorders and hematological diseases. The company employs its proprietary peptide technology platform to advance a diverse pipeline of therapeutic candidates aimed at improving patient outcomes. Located in Newark, California, Protagonist is strategically focused on driving scientific innovation and addressing critical healthcare challenges, underpinned by a strong commitment to research and development. With a unique approach to peptide therapeutics, Protagonist is well-positioned to make a meaningful impact in the biopharmaceutical landscape.